Clinical Management of Cytokine Release Syndrome in CAR-T Therapy

News
Video

Expert panelists explore approaches to grading and managing Cytokine Release Syndrome (CRS) in CAR-T therapy, discussing effective strategies to mitigate severity and key differences in CRS management protocols between ide-cel and cilta-cel.

Video content above is prompted by the following:

  • Cytokine Release Syndrome (CRS) is a major concern in CAR-T therapy. How do you approach the grading and management of CRS?
  • Which strategies have you found most effective for reducing the severity of CRS?
  • Are there notable differences in CRS management protocols between ide-cel and cilta-cel?

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with red hair and glasses wearing a black blouse and cross necklace in front of a dark blue background
Photo of a man wearing a suit with a blue tie in front of a dark blue background
4 experts in this video
4 experts in this video
Photo of a man wearing glasses and a suit in front of a blue background
Related Content